close

Mergers and Acquisitions

1 26 27 28
Number of results: 557
Date Acquired company Acquiring company Amount Related
2011-03-22 Zhejiang Tianyuan (China) Novartis (Switzerland) undisclosed

Vaccines

2011-03-15 Theragenics (USA) Eckert & Ziegler Strahlen- und Medizintechnik (Germany) $74 million
2011-03-15 PVT (Germany) Roche (Switzerland) € 65 million and up to € 20 million upon reaching performance-related milestones.

clinical diagnostics

2011-03-08 Crucell (The Netherlands) Johson&Johnson - J&J (USA) €1.75 billion

Vaccines
Infectious diseases
Bioproduction

2011-03-02 veterinary business of Riemser Arzneimittel (Germany) Ecuphar (Belgium)

Veterinary medicine

2011-02-28 Avogadro (France) Amatsi (France) undisclosed

Drug development services

2011-02-25 Cellerix (Spain) Tigenix (Belgium)

stem cell
regenerative medicine
cell therapy

2011-02-24 Lancaster Laboratories (USA) Eurofins Scientific (France) approximately $ 200 million

Pharmaceutical product testing services and cGMP Quality Control

2011-02-22 iNovia (Sweden) Kancera (Sweden) undisclosed

services

2011-02-21 Prostrakan (UK) Kyowa Hakko Kirin (Japan) £ 292 million(€ 345,3 million)

Specialty pharma

2011-02-16 Genzyme (USA) Sanofi Aventis (France) $ 20,1 billion

Rare diseases
Endocrinology
Hematology
Oncology
Biosurgery

2011-02-09 Kinaxo (Germany) Evotec (Germany) €12 million

Drug discovery
Drug development
Oncology

2011-01-31 UK manufacturing facility from RecipharmCobra Biologics Oxford BioMedica (UK) £1.9 million (€2.2 million)

Manufacturing
Production
Gene therapy

2011-01-25 Santhera Pharmaceuticals (Switzerland) Newron Pharmaceuticals (Italy)
2011-01-24 Genoptix (USA) Novartis (Switzerland) $470 million (€344 million)

Personalized medicine

2011-01-10 Synosia Therapeutics (Switzerland) Biotie Therapies (Finland) € 93.6 million
0000-00-00